Abercrombie & Fitch raises outlook after quarterly sales surge 20%

Abercrombie & Fitch raises outlook after quarterly sales surge 20%


Abercrombie & Fitch.

Courtesy: Abercrombie & Fitch

Abercrombie & Fitch on Tuesday blew past estimates as it posted a 20% jump in sales thanks to a strong back-to-school shopping season and growth at both its namesake brand and Hollister. 

The longtime mall retailer, which has bounced back after years of stagnation, also raised its outlook again as it continues to defy an overall slowdown across the apparel industry. 

Shares of the company fell more than 9% after markets opened, however. Through Monday’s close, the stock was up 215% on the year.

Here’s how Abercrombie did in its fiscal third quarter compared with what Wall Street was anticipating, based on a survey of analysts by LSEG, formerly known as Refinitiv:

  • Earnings per share: $1.83 vs. $1.18 expected
  • Revenue: $1.06 billion vs. $981 million expected

The company’s reported net income for the three-month period that ended Oct. 28 was $96.2 million, or $1.83 per share, compared with a loss of $2.21 million, or 4 cents per share, a year earlier. 

Sales rose to $1.06 billion from $880 million a year earlier. 

For its fourth quarter, Abercrombie expects net sales growth to be up low double-digits compared to the prior year, which is in line with the 11.6% growth analysts had expected, according to LSEG. 

It expects its operating margin to be in the range of 12% to 14%, compared to 7.7% in the year ago period and ahead of expectations of 11.3%, according to StreetAccount. The expected uptick is driven by a higher gross profit rate, lower freight costs and higher sales prices. 

For the full year, the company expects net sales to grow between 12% to 14%, up from a previous outlook of around 10% and ahead of the 10.8% uptick that analysts had expected, according to LSEG. It’s forecasting an operating margin of around 10%, up from its previous range of 8% to 9%, which is what analysts had expected, according to StreetAccount. The expected increase is driven by lower freight and raw material costs. 

Abercrombie CEO Fran Horowitz told analysts the company has seen an “encouraging” start to the holiday shopping season. But its forecast for the quarter failed to impress Wall Street, and was only in-line with consensus estimates despite the strong quarter.

“Our teams have worked hard to align our product and promotional messaging to set us up for a successful holiday across brands,” Horowitz said on a call with analysts. “We’re confident our customers will love what we have for them this holiday season.

Horowitz added: “While the macro environment remains challenging and uncertain, we’ve proven that we can deliver growth across brands and regions if we stay focused on our customer and execute our playbook.”

A similar dynamic was seen at rival American Eagle, which also reported earnings Tuesday morning. While the fellow mall retailer also performed ahead of expectations and raised its guidance, American Eagle’s holiday forecast failed to wow Wall Street, sending its stock plummeting.

During the quarter, Abercrombie saw sales at its namesake brand grow by 30% to $548 million and revenue at Hollister grow by 11% to $509 million. Same store sales were up 16% across both brands.

Abercrombie’s stock has soared this year as the company’s transformation continues to bear fruit. For years, Abercrombie was known for its branded t-shirts and jeans and shirtless male models, which in turn prompted critics to accuse the company of racism and exclusivity.

In the years since Horowitz took over as the brand’s CEO, Abercrombie has transformed itself into an inclusive retailer with a product assortment that continues to resonate with consumers.

Read the full earnings release here.



Source

Where the blockbuster weight loss drug market stands today — and what’s coming next
Business

Where the blockbuster weight loss drug market stands today — and what’s coming next

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Hollie Adams | Reuters The appetite for blockbuster weight loss and diabetes drugs is far from satisfied.  From fresh competition to new uses, the market is quickly vaulting into a new stage of […]

Read More
Just 5% of CRE companies have achieved their AI goals. Here’s why
Business

Just 5% of CRE companies have achieved their AI goals. Here’s why

Diminishing perspective of downtown London skyscrapers Chunyip Wong | Istock | Getty Images A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large […]

Read More
Chocolate’s reign over Halloween is under threat from inflation, tariffs and high cocoa prices
Business

Chocolate’s reign over Halloween is under threat from inflation, tariffs and high cocoa prices

A customer shops for Halloween candy at a Walmart Supercenter on October 16, 2024 in Austin, Texas.  Brandon Bell | Getty Images The scariest thing haunting Halloween this year isn’t a ghost, goblin or ghoul — it’s the price of chocolate. From Snickers to Reese’s to Twix, one of America’s favorite indulgences is getting more […]

Read More